We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Short-Term Absorbable Sutures Not Recommended in Hernia Repair

By HospiMedica International staff writers
Posted on 09 Feb 2011
The use of short-term absorbable sutures for mesh fixation following Lichtenstein inguinal hernioplasty was associated with a more than two-fold increased risk of hernia recurrence, according to a new study.

Researchers at Skaraborg Hospital (Falkoping, Sweden) conducted a population-based registry review, using data from the Swedish nationwide Hernia Registry to analyze all 82,015 Lichtenstein inguinal hernioplasty repairs in Sweden with sutured mesh fixation in adolescents and adults over an 8-year period (2002-2009). More...
In the vast majority of procedures (95.7%), the mesh was secured with standard nonabsorbable sutures. Long-term absorbable sutures were used in 1,938 cases (2.4%) and short-term absorbable sutures in 1,210 cases (1.5%).

The researchers found that in multiregression analysis, there was no significant difference in risk of reoperation due to hernia recurrence after mesh fixation with these sutures. The use of short-term absorbable sutures, however, more than doubled the risk of reoperation due to hernia recurrence, with a risk ratio (RR) of 2.23. According to the researchers, the findings are in line with results obtained from studies on abdominal wound closure, where short-term absorbable sutures were shown to raise the risk for incisional hernia formation independently. The study was published in the January 2011 issue of Archives of Surgery.

"To minimize hernia recurrence following the Lichtenstein inguinal hernioplasty, we recommend either nonabsorbable or long-term absorbable sutures for the mesh fixation in all cases and advise against short-term absorbable sutures,” concluded lead author Bengt Novik, MD, and colleagues of the department of surgery. "We challenged and were able to refute the previous opinion of many authoritative hernia experts that have dictated that permanent mesh fixation sutures are compulsory to guarantee the lowest possible recurrence rates in hernia surgery.”

"The only reason why we would want surgeons to change from a permanent to an absorbable suture material would be if it can be shown that such mesh fixation may lower the incidence of chronic posthernioplasty pain (CPHP) and our study was not meant to answer that question,” added Dr. Novik. "Hopefully, we have now removed a major obstacle to perform studies on the influence of different mesh fixation materials on the incidence, severity, and duration of CPHP.”

Related Links:
Skaraborg Hospital




Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.